Drug profile · INN
corticorelin ovine triflutate
ACTHREL
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
corticorelin ovine triflutate (ACTHREL) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN corticorelin ovine triflutate
Brand ACTHREL
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is corticorelin ovine triflutate?
corticorelin ovine triflutate (ACTHREL) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for corticorelin ovine triflutate?
ACTHREL is a marketed brand name for corticorelin ovine triflutate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of corticorelin ovine triflutate?
corticorelin ovine triflutate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.